CoChat

An Evolved Adeno-associated Viral Variant Enhances Gene Delivery and Gene Targeting in Neural Stem Cells

Open access
Jang, Jae-Hyung, Koerber, James T, Kim, Jung-Suk, Asuri, Prashanth, Vazin, Tandis, Bartel, Melissa, Keung, Albert, Kwon, Inchan, Park, Kook In, Schaffer, David V · 2011 · Molecular Therapy
Cited by 101

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

Gene delivery to, and gene targeting in, stem cells would be a highly enabling technology for basic science and biomedical application. Adeno-associated viral (AAV) vectors have demonstrated the capacity for efficient delivery to numerous cells, but their application to stem cells has been limited by low transduction efficiency. Due to their considerable advantages, however, engineering AAV delivery systems to enhance gene delivery to stem cells may have an impact in stem cell biology and therapy. Therefore, using several diverse AAV capsid libraries-including randomly mutagenized, DNA shuffled, and random peptide insertion variants-we applied directed evolution to create a "designer" AAV vector with enhanced delivery efficiency for neural stem cells (NSCs). A novel AAV variant, carrying an insertion of a selected peptide sequence on the surface of the threefold spike within the heparin-binding site, emerged from this evolution. Importantly, this evolved AAV variant mediated efficient gene delivery to rat, mouse, and human NSCs, as well as efficient gene targeting within adult NSCs, and it is thus promising for applications ranging from basic stem cell biology to clinical translation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/mt.2010.287

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 39

  1. Yates, 2006, Progress and prospects: gene transfer into embryonic stem cells, Gene Ther, 13, 1431, 10.1038/sj.gt.3302854 · DOI
  2. Madeira, 2010, Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy, J Biomed Biotechnol, 2010, 735349, 10.1155/2010/735349 · DOI
  3. Jo, 2008, Non-viral gene transfection technologies for genetic engineering of stem cells, Eur J Pharm Biopharm, 68, 90, 10.1016/j.ejpb.2007.04.021 · DOI
  4. Singer, 2006, Rapid generation of knockdown transgenic mice by silencing lentiviral vectors, Nat Protoc, 1, 286, 10.1038/nprot.2006.44 · doi:10.1038/nprot.2006.44
  5. Marumoto, 2009, Development of a novel mouse glioma model using lentiviral vectors, Nat Med, 15, 110, 10.1038/nm.1863 · DOI · Paper page
  6. Fan, 2002, Transient disruption of autocrine TGF-beta signaling leads to enhanced survival and proliferation potential in single primitive human hemopoietic progenitor cells, J Immunol, 168, 755, 10.4049/jimmunol.168.2.755 · DOI · Paper page
  7. Silva, 2008, Promotion of reprogramming to ground state pluripotency by signal inhibition, PLoS Biol, 6, e253, 10.1371/journal.pbio.0060253 · DOI · Paper page
  8. Hester, 2009, Two factor reprogramming of human neural stem cells into pluripotency, PLoS ONE, 4, e7044, 10.1371/journal.pone.0007044 · DOI · Paper page
  9. Gropp, 2003, Stable genetic modification of human embryonic stem cells by lentiviral vectors, Mol Ther, 7, 281, 10.1016/S1525-0016(02)00047-3 · DOI · Paper page
  10. Suzuki, 2008, Highly efficient transient gene expression and gene targeting in primate embryonic stem cells with helper-dependent adenoviral vectors, Proc Natl Acad Sci USA, 105, 13781, 10.1073/pnas.0806976105 · DOI
  11. Conrad, 2007, Genetically engineered stem cells for therapeutic gene delivery, Curr Gene Ther, 7, 249, 10.2174/156652307781369119 · DOI
  12. Lim, 2010, Specific insertions of zinc finger domains into Gag-Pol yield engineered retroviral vectors with selective integration properties, Proc Natl Acad Sci USA, 107, 12475, 10.1073/pnas.1001402107 · DOI
  13. Urnov, 2005, Highly efficient endogenous human gene correction using designed zinc-finger nucleases, Nature, 435, 646, 10.1038/nature03556 · DOI · Paper page
  14. Verma, 2005, Gene therapy: twenty-first century medicine, Annu Rev Biochem, 74, 711, 10.1146/annurev.biochem.74.050304.091637 · DOI · Paper page
  15. Kaplitt, 1994, Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain, Nat Genet, 8, 148, 10.1038/ng1094-148 · DOI · Paper page
  16. Flannery, 1997, Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus, Proc Natl Acad Sci USA, 94, 6916, 10.1073/pnas.94.13.6916 · DOI · Paper page
  17. Russell, 1998, Human gene targeting by viral vectors, Nat Genet, 18, 325, 10.1038/ng0498-325 · DOI · Paper page
  18. Chamberlain, 2004, Gene targeting in stem cells from individuals with osteogenesis imperfecta, Science, 303, 1198, 10.1126/science.1088757 · DOI · Paper page
  19. Rogers, 2008, Production of CFTR-null and CFTR-DeltaF508 heterozygous pigs by adeno-associated virus-mediated gene targeting and somatic cell nuclear transfer, J Clin Invest, 118, 1571, 10.1172/JCI34773 · DOI · Paper page
  20. Smith-Arica, 2003, Infection efficiency of human and mouse embryonic stem cells using adenoviral and adeno-associated viral vectors, Cloning Stem Cells, 5, 51, 10.1089/153623003321512166 · DOI · Paper page
  21. Hughes, 2002, Viral-mediated gene transfer to mouse primary neural progenitor cells, Mol Ther, 5, 16, 10.1006/mthe.2001.0512 · DOI · Paper page
  22. Temple, 2001, The development of neural stem cells, Nature, 414, 112, 10.1038/35102174 · DOI · Paper page
  23. Lai, 2003, Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo, Nat Neurosci, 6, 21, 10.1038/nn983 · DOI · Paper page
  24. Excoffon, 2009, Directed evolution of adeno-associated virus to an infectious respiratory virus, Proc Natl Acad Sci USA, 106, 3865, 10.1073/pnas.0813365106 · DOI · Paper page
  25. Müller, 2003, Random peptide libraries displayed on adeno-associated virus to select for targeted gene therapy vectors, Nat Biotechnol, 21, 1040, 10.1038/nbt856 · DOI · Paper page
  26. Opie, 2003, Identification of amino acid residues in the capsid proteins of adeno-associated virus type 2 that contribute to heparan sulfate proteoglycan binding, J Virol, 77, 6995, 10.1128/JVI.77.12.6995-7006.2003 · DOI · Paper page
  27. Hansen, 2000, Impaired intracellular trafficking of adeno-associated virus type 2 vectors limits efficient transduction of murine fibroblasts, J Virol, 74, 992, 10.1128/JVI.74.2.992-996.2000 · DOI · Paper page
  28. Kim, 2009, Direct reprogramming of human neural stem cells by OCT4, Nature, 461, 643, 10.1038/nature08436 · DOI · Paper page
  29. Kim, 2009, Oct4-induced pluripotency in adult neural stem cells, Cell, 136, 411, 10.1016/j.cell.2009.01.023 · DOI · Paper page
  30. Palmer, 1999, Fibroblast growth factor-2 activates a latent neurogenic program in neural stem cells from diverse regions of the adult CNS, J Neurosci, 19, 8487, 10.1523/JNEUROSCI.19-19-08487.1999 · DOI · Paper page
  31. Kim, 2006, Human neurospheres derived from the fetal central nervous system are regionally and temporally specified but are not committed, Exp Neurol, 199, 222, 10.1016/j.expneurol.2006.03.015 · DOI
  32. Perabo, 2003, In vitro selection of viral vectors with modified tropism: the adeno-associated virus display, Mol Ther, 8, 151, 10.1016/S1525-0016(03)00123-0 · DOI · Paper page
  33. Stemmer, 1994, Rapid evolution of a protein in vitro by DNA shuffling, Nature, 370, 389, 10.1038/370389a0 · DOI · Paper page
  34. Zhao, 1997, Optimization of DNA shuffling for high fidelity recombination, Nucleic Acids Res, 25, 1307, 10.1093/nar/25.6.1307 · DOI · Paper page
  35. Batard, 2001, Transfer of high copy number plasmid into mammalian cells by calcium phosphate transfection, Gene, 270, 61, 10.1016/S0378-1119(01)00467-X · DOI · Paper page
  36. Koerber, 2006, Construction of diverse adeno-associated viral libraries for directed evolution of enhanced gene delivery vehicles, Nat Protoc, 1, 701, 10.1038/nprot.2006.93 · DOI
  37. Lois, 2002, Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors, Science, 295, 868, 10.1126/science.1067081 · DOI · Paper page
  38. Yu, 2006, Selection of novel vesicular stomatitis virus glycoprotein variants from a peptide insertion library for enhanced purification of retroviral and lentiviral vectors, J Virol, 80, 3285, 10.1128/JVI.80.7.3285-3292.2006 · DOI · Paper page
  39. Leonard, 2008, HIV evades RNA interference directed at TAR by an indirect compensatory mechanism, Cell Host Microbe, 4, 484, 10.1016/j.chom.2008.09.008 · DOI

Cited by

See all 101

Metadata

Authors
Jang, J.-H., Koerber, J. T., Kim, J.-S., Asuri, P., Vazin, T., Bartel, M., Keung, A., Kwon, I., Park, K. I., & Schaffer, D. V.
Venue
Molecular Therapy
Publisher
Elsevier BV
Published
2011-04
Volume
19
Issue
4
Pages
667-675
ISSN
1525-0016 (ISSN-L)
OpenAlex
W2103037531
Cited by
101
References
9
FWCI
6.76
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.